The Functional Assessment of Cancer Therapy – General Population (FACT-GP) is a shortened, 21-item version of the FACT-G designed to be administered to the general population. Items from the FACT-G making reference to illness or treatment have been removed, and the instrument measures four domains of HRQOL: Physical, social/family, emotional and functional well-being.
Functional Assessment of Cancer Therapy – General Population (FACT-GP)
NUMBER OF ITEMS:
General population 18 years and older
Past 7 days
5 point Likert-type scale
Paper and electronic
Self-administration and interview when applicable
Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being
TIME FOR COMPLETION:
Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. SAS/SPSS algorithms available.
Available translations of the FACT-GP can be obtained by registering for permission. Users are not permitted to translate the FACT-GP without permission from FACIT.org. Permission from FACIT.org to translate the FACT-GP may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system.
Please contact us for more information.
Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.
Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.
To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.
Cella D.F., Tulsky D.S., Gray G., Sarafian B., Lloyd S., Linn E., Bonomi A., Silberman M., Yellen S.B., Winicour P., Brannon J., Eckberg K., Purl S., Blendowski C., Goodman M., BarnicleM., Stewart I., McHale M., Bonomi P., Kaplan E., Taylor S., Thomas C., Harris J. The Functional Assessment of Cancer Therapy (FACT) Scale: Development and validation of the general measure. Journal of Clinical Oncology 1993; 11(3): 570-579.
Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320.
Brucker P.S., Yost K.J., Cashy J., Webster K., Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy – General (FACT-G). Evaluation & the Health Professions 2005; 28(2): 192-211.
Cella D., Zagari M.J., Vandoros C., Gagnon D.D., Hurtz H.J., Nortier J.W.R. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. Journal of Clinical Oncology 2003; 21(2): 366-373.
Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232.
Lindqvist Bagge, AS., Carlander, A., Fahlke, C. et al. Health-related quality of life (FACT-GP) in Sweden. Health Qual Life Outcomes 18 , 172 (2020). https://doi.org/10.1186/s12955-020-01420-1
Pearman T., Yanez B., Peipert J., Wortman K., Beaumont J., Cella D. Ambulatory cancer and US general population reference values and cutoff scores for the Functional Assessment of Cancer Therapy. Cancer 2014: 2902-2909.
Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85.
Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions2005; 28(2): 172-191.